{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:33:30Z","timestamp":1787765610897,"version":"build-2784847793"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Pneumothoraces associated with infectious diseases have a higher rate of treatment failure and longer length of hospital stay than those associated with obstructive lung diseases and malignancy. Little is mentioned in the medical literature concerning the use of endobronchial 1-way valves in treating alveolar-pleural fistulae (APF) caused by pulmonary infections.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A 7-year, single-center, retrospective analysis of patients consented for exempted off-label use of the Olympus Spiration Implantable Endobronchial Valve system to control prolonged air leaks at the University of Cincinnati Medical Center.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Nineteen consecutive patients had 22 separate APF events from pulmonary infections during which a total of 101 valves were placed over 23 procedures (average 4.4\u00b12.8 valves per procedure). The average time from the first chest tube placement to valve placement was 23.4\u00b120.8 days (range, 2 to 84\u2009d). Chest tubes were successfully removed in 19 (86.4%) of 22 APF events without further intervention. In events not including chest tubes remaining solely for empyema treatment after cessation of air leak (n=14), the average time from valve placement to the removal of all chest tubes was 12.8\u00b120.2 days (1 to 81\u2009d). Thirty and ninety day all-cause mortality was 15.8%. On average, valves were removed 64.1\u00b127.1 days (range, 38 to 135\u2009d) after placement.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Based on our institutional experience, endobronchial valves may be a treatment option for select patients with persistent air leaks caused by pulmonary infections. Further standardized and comparative studies are required to fully understand the risks and benefits of this treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/lbr.0000000000000689","type":"journal-article","created":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T04:23:35Z","timestamp":1590467015000},"page":"47-52","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Endobronchial Valve Placement for Persistent Air Leaks Secondary to Pulmonary Infections"],"prefix":"10.1097","volume":"28","author":[{"given":"Arjan S.","family":"Flora","sequence":"first","affiliation":[{"name":"Interventional Pulmonology Service, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Cincinnati Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Aragaki-Nakahodo","sequence":"additional","affiliation":[{"name":"Interventional Pulmonology Service, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Cincinnati Medical Center, Cincinnati, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Benzaquen","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, and Sleep Medicine, Einstein Medical Center, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,5,22]]},"reference":[{"key":"R1-20240809","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.21037\/jtd.2017.10.122","article-title":"Persistent air leaks: a review with an emphasis on bronchoscopic management","volume":"9","author":"Lazarus","year":"2017","journal-title":"J Thorac Dis"},{"key":"R3-20240809","first-page":"6","article-title":"The case for using the spiration valve system to treat patients with prolonged air leaks (LIT-04683-02)","volume":"1","author":"Benzaquen","year":"2017","journal-title":"Olympus Respiratory America"},{"key":"R4-20240809","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ajem.2010.09.014","article-title":"Secondary spontaneous pneumothorax: which associated conditions benefit from pigtail catheter treatment?","volume":"30","author":"Chen","year":"2012","journal-title":"Am J Emerg Med"},{"key":"R5-20240809","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/INF.0b013e31821b10c3","article-title":"Necrotizing Pneumococcal Pneumonia with bronchopleural fistula among children in Taiwan","volume":"30","author":"Hsieh","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R6-20240809","first-page":"1","article-title":"Septic pulmonary emboli causing recurrent bilateral pneumothoraces in a patient with right sided endocarditis: a case report and review of literature","volume":"6","author":"Kapoor","year":"2018","journal-title":"SAGE Open Med Case Rep"},{"key":"R7-20240809","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1378\/chest.119.2.590","article-title":"Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi Consensus Statement","volume":"119","author":"Baumann","year":"2001","journal-title":"Chest"},{"key":"R8-20240809","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ejcts.2010.07.004","article-title":"Closure of persisting air leaks in patients with severe pleural empyema \u2013 use of endoscopic one-way endobronchial valve","volume":"39","author":"Schweigert","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"issue":"suppl 10","key":"R9-20240809","doi-asserted-by":"crossref","first-page":"S1034","DOI":"10.21037\/jtd.2017.05.47","article-title":"Bronchoscopic management of prolonged air leak","volume":"9","author":"Keshishyan","year":"2017","journal-title":"J Thorac Dis"},{"key":"R10-20240809","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12931-017-0666-y","article-title":"Endobronchial one-way valves for treatment of persistent air leaks: a systematic review","volume":"18","author":"Ding","year":"2017","journal-title":"Respiratory Res"},{"key":"R13-20240809","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1164\/rccm.201902-0383OC","article-title":"The EMPROVE Trial\u2014a randomized, controlled multicenter clinical study to evaluate the safety and effectiveness of the Spiration\u00ae Valve System for single lobe treatment of severe emphysema","volume":"200","author":"Criner","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"R14-20240809","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa0900928","article-title":"A randomized study of endobronchial valves for advanced emphysema","volume":"363","author":"Sciurba","year":"2010","journal-title":"N Engl J Med"},{"key":"R15-20240809","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000494327","article-title":"The REACH Trial: a randomized controlled trial assessing the safety and effectiveness of the Spiration\u00ae Valve System in the treatment of severe emphysema","volume":"97","author":"Li","year":"2019","journal-title":"Respiration"},{"key":"R16-20240809","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1164\/rccm.201803-0590OC","article-title":"A multicenter randomized controlled trial of Zephyr Endobronchial Valve treatment in heterogeneous emphysema (LIBERATE)","volume":"198","author":"Criner","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R17-20240809","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1164\/rccm.201607-1383OC","article-title":"Endobronchial valve therapy in patients with homogenous emphysema. Results from the IMPACT study","volume":"194","author":"Valipour","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"R18-20240809","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1164\/rccm.201707-1327OC","article-title":"A multicenter randomized controlled trial of Zephyr Endobronchial Valve treatment in heterogenous emphysema (TRANSFORM)","volume":"196","author":"Kemp","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R19-20240809","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.5588\/ijtld.16.0033","article-title":"Endobronchial valve treatment of destructive multidrug resistant tuberculosis","volume":"20","author":"Levin","year":"2016","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["Journal of Bronchology &amp; Interventional Pulmonology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/LBR.0000000000000689","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T15:17:36Z","timestamp":1723216656000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/LBR.0000000000000689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,22]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/lbr.0000000000000689","relation":{},"ISSN":["1944-6586"],"issn-type":[{"value":"1944-6586","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,22]]},"assertion":[{"value":"2019-09-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}